rs120074190
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PM2_SupportingPS4PS3PM3_SupportingPP3
This summary comes from the ClinGen Evidence Repository: NM_000218.3(KCNQ1):c.1766G>A is a missense variant in KCNQ1 that substitutes glycine with aspartic acid at codon 589. This variant is present in gnomAD v.4.1.0 at a maximum allele frequency of 0.0000008.474, with 1 allele / 1,180,024 total alleles in the European (non-Finnish) population, which is lower than the ClinGen Potassium Channel Arrhythmia VCEP PM2_Supporting threshold of <0.00001 (PM2_Supporting). Please note that the variant has a higher frequency of 0.0005504 (35 alleles / 63,586 total alleles) in the European Finnish population. which is not one of the 5 continental populations eligible to meet a population code. The variant has been reported in 34 apparently unrelated probands affected with long QT syndrome 1 (PS4; PMID:11216980). The variant has also been detected in at least 2 apparently unrelated probands with Jervell and Lange-Nielsen syndrome who had both a long QTc interval and congenital deafness. 1 proband was compound heterozygous for this variant and the p.Tyr171Ter variant, which has not yet been classified by the VCEP, confirmed in trans by family testing, while the other proband was homozygous for the variant (0.5 pts, PM3_Supporting, PMID:11216980). The variant has been reported to segregate with long QT syndrome 1 through the proband and at least 1 confirmed affected family member with QTc >480 ms, however, this does not meet the requirement of at least 2 segregations to meet PP1 (PMID:11216980). This variant has been reported in at least one affected proband exhibiting QTc prolongation and an exercise-related syncopal spell, however the QTc is not available to evaluate in relation to the required threshold of >480 ms, so PP4 is not met (PMID:10483966). The computational predictor REVEL gives a score of 0.863, which is above the ClinGen Potassium Channel Arrhythmia VCEP PP3 threshold of >0.75 and predicts a damaging effect on KCNQ1 function (PP3). This variant has been shown to disrupt KCNQ1 function in experimental assays from at least 5 independent research groups, including manual patch-clamp (PMID:11216980, PMID:25344363, PMID:22095730, PMID:11799244), electrophysiology studies in iPSC-derived cardiomyocytes (PMID:15528464), and cell surface localization (PMID:25344363). The combination of 5 electrophysiology studies with 1 protein metabolism study satisfies the VCEP requirement for the strong level of the experimental code (PS3). Another missense variant in the same codon, c.1765G>A (p.Gly589Ser) has been reported in association with long QT syndrome 1 (PMID:31565860), however, PM5 has not been considered in order to avoid circularity. In summary, this variant meets the criteria to be classified as pathogenic for long QT syndrome 1 based on the ACMG/AMP criteria applied, as specified by the ClinGen Potassium Channel Arrhythmia VCEP: PS3, PS4, PM2_Supporting, PM3_Supporting, and PP3. (VCEP specifications version 1.0.0; date of approval 03/04/2025). LINK:https://erepo.genome.network/evrepo/ui/classification/CA006347/MONDO:0100316/112
Frequency
Consequence
NM_000218.3 missense
Scores
Clinical Significance
Conservation
Publications
- long QT syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- long QT syndrome 1Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- Jervell and Lange-Nielsen syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Jervell and Lange-Nielsen syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- atrial fibrillation, familial, 3Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- short QT syndromeInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet
- short QT syndrome type 2Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- familial atrial fibrillationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Jervell and Lange-Nielsen syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hypertrophic cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000218.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| KCNQ1 | TSL:1 MANE Select | c.1766G>A | p.Gly589Asp | missense | Exon 15 of 16 | ENSP00000155840.2 | P51787-1 | ||
| KCNQ1 | TSL:1 | c.1385G>A | p.Gly462Asp | missense | Exon 15 of 16 | ENSP00000334497.5 | P51787-2 | ||
| KCNQ1 | c.1763G>A | p.Gly588Asp | missense | Exon 15 of 16 | ENSP00000581056.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152192Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000478 AC: 12AN: 250966 AF XY: 0.0000442 show subpopulations
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1461412Hom.: 0 Cov.: 32 AF XY: 0.0000206 AC XY: 15AN XY: 727038 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152192Hom.: 0 Cov.: 33 AF XY: 0.0000807 AC XY: 6AN XY: 74334 show subpopulations
Age Distribution
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at